SUPPLY, DISTRIBUTION AND LICENSING AGREEMENTSupply, Distribution and Licensing Agreement • September 24th, 2014 • Prima BioMed LTD • Pharmaceutical preparations • England
This Supply, Distribution and Licensing Agreement dated as of 19 February 2014 (“Effective Date”) is entered into between Prima BioMed Ltd., a corporation incorporated under the laws of Australia with its principal place of business at Level 7,151 Macquarie Street, Sydney NSW, 2000, Australia (“Prima BioMed”), and Neopharm Ltd., a corporation incorporated under the laws of Israel, with registered offices at 6 Hashiloach st Kiryat Matalon, Petach Tikva, Israel (“Neopharm”). “Parties” shall mean Prima BioMed and Neopharm, and “Party” shall mean either of Prima BioMed or Neopharm, as the context requires.
ContractTransition Services Agreement • September 24th, 2014 • Prima BioMed LTD • Pharmaceutical preparations
[***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • September 24th, 2014 • Prima BioMed LTD • Pharmaceutical preparations • California
THIS Separation Agreement and Release (this “Agreement”) is made by and between Matthew Lehman (the “Employee”), and Prima Biomed Ltd., an Australian limited company (the “Company”).
Level 7, 151 Macquarie Street Sydney NSW 2000 AustraliaPrima BioMed LTD • September 24th, 2014 • Pharmaceutical preparations
Chief Executive Officer Employment Agreement between Prima Biomed Ltd.Prima BioMed LTD • September 24th, 2014 • Pharmaceutical preparations
Executive- and Business Manager Employment Contract between Prima Biomed GmbH Deutscher Platz 5E 04103 Leipzig (hereinafter, known as “Company”) and Mr. Marc Voigt (hereinafter, known as “Mr. Voigt” or “Executive/Managing Director”)Prima BioMed LTD • September 24th, 2014 • Pharmaceutical preparations
(hereinafter, the “Company” and “Mr. Voigt” or “Executive/Managing Director together known as the “Parties” and each of them a “Party”)
ContractTransition Services Agreement • September 24th, 2014 • Prima BioMed LTD • Pharmaceutical preparations • Victoria
[***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
